Q2 2020

Source filing unavailable

Q2 2020 · —

Revenue

$93.20M

−56.7% vs Q2 2019

Net Income

-$55.40M

N/M vs Q2 2019

EPS Diluted

-$0.74

N/M vs Q2 2019

Operating Income-$68,300,000N/M

Operating Cash Flowderived$30,000,000−4.8%

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2016	Q2 2015
Revenue	$93.20M	$215.40M	$193.30M	$184.40M
Net Income	-$55.40M	-$4.20M	$37.10M	$24.00M
EPS Diluted	-$0.74	-$0.06	$0.50	$0.32

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR